These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 23145191)
1. Stage progression and neurological symptoms in Trypanosoma brucei rhodesiense sleeping sickness: role of the CNS inflammatory response. MacLean L; Reiber H; Kennedy PG; Sternberg JM PLoS Negl Trop Dis; 2012; 6(10):e1857. PubMed ID: 23145191 [TBL] [Abstract][Full Text] [Related]
2. Interleukin (IL)-6 and IL-10 Are Up Regulated in Late Stage Trypanosoma brucei rhodesiense Sleeping Sickness. Kato CD; Alibu VP; Nanteza A; Mugasa CM; Matovu E PLoS Negl Trop Dis; 2015 Jun; 9(6):e0003835. PubMed ID: 26090964 [TBL] [Abstract][Full Text] [Related]
3. Focus-specific clinical profiles in human African Trypanosomiasis caused by Trypanosoma brucei rhodesiense. MacLean LM; Odiit M; Chisi JE; Kennedy PG; Sternberg JM PLoS Negl Trop Dis; 2010 Dec; 4(12):e906. PubMed ID: 21151878 [TBL] [Abstract][Full Text] [Related]
4. Clinical presentation of T.b. rhodesiense sleeping sickness in second stage patients from Tanzania and Uganda. Kuepfer I; Hhary EP; Allan M; Edielu A; Burri C; Blum JA PLoS Negl Trop Dis; 2011 Mar; 5(3):e968. PubMed ID: 21407802 [TBL] [Abstract][Full Text] [Related]
5. Metabolic Profiling of Central Nervous System Disease in Trypanosoma brucei rhodesiense Infection. Lamour SD; Alibu VP; Holmes E; Sternberg JM J Infect Dis; 2017 Dec; 216(10):1273-1280. PubMed ID: 28927234 [TBL] [Abstract][Full Text] [Related]
8. Severity of human african trypanosomiasis in East Africa is associated with geographic location, parasite genotype, and host inflammatory cytokine response profile. MacLean L; Chisi JE; Odiit M; Gibson WC; Ferris V; Picozzi K; Sternberg JM Infect Immun; 2004 Dec; 72(12):7040-4. PubMed ID: 15557627 [TBL] [Abstract][Full Text] [Related]
9. Dot enzyme-linked immunosorbent assay for more reliable staging of patients with Human African trypanosomiasis. Courtioux B; Bisser S; M'belesso P; Ngoungou E; Girard M; Nangouma A; Josenando T; Jauberteau-Marchan MO; Bouteille B J Clin Microbiol; 2005 Sep; 43(9):4789-95. PubMed ID: 16145142 [TBL] [Abstract][Full Text] [Related]
10. Clinical and Neuropathogenetic Aspects of Human African Trypanosomiasis. Kennedy PGE; Rodgers J Front Immunol; 2019; 10():39. PubMed ID: 30740102 [TBL] [Abstract][Full Text] [Related]
11. Intrathecal cytokine responses in Trypanosoma brucei rhodesiense sleeping sickness patients. Maclean L; Odiit M; Sternberg JM Trans R Soc Trop Med Hyg; 2006 Mar; 100(3):270-5. PubMed ID: 16343570 [TBL] [Abstract][Full Text] [Related]
12. Treatment failure related to intrathecal immunoglobulin M (IgM) synthesis, cerebrospinal fluid IgM, and interleukin-10 in patients with hemolymphatic-stage sleeping sickness. Lejon V; Robays J; N'Siesi FX; Mumba D; Hoogstoel A; Bisser S; Reiber H; Boelaert M; Büscher P Clin Vaccine Immunol; 2007 Jun; 14(6):732-7. PubMed ID: 17428948 [TBL] [Abstract][Full Text] [Related]
13. Evaluating the impact of targeting livestock for the prevention of human and animal trypanosomiasis, at village level, in districts newly affected with T. b. rhodesiense in Uganda. Hamill L; Picozzi K; Fyfe J; von Wissmann B; Wastling S; Wardrop N; Selby R; Acup CA; Bardosh KL; Muhanguzi D; Kabasa JD; Waiswa C; Welburn SC Infect Dis Poverty; 2017 Feb; 6(1):16. PubMed ID: 28162093 [TBL] [Abstract][Full Text] [Related]
14. Estimating the burden of rhodesiense sleeping sickness during an outbreak in Serere, eastern Uganda. Fèvre EM; Odiit M; Coleman PG; Woolhouse ME; Welburn SC BMC Public Health; 2008 Mar; 8():96. PubMed ID: 18366755 [TBL] [Abstract][Full Text] [Related]
15. Factors influencing passive surveillance for T. b. rhodesiense human african trypanosomiasis in Uganda. Acup C; Bardosh KL; Picozzi K; Waiswa C; Welburn SC Acta Trop; 2017 Jan; 165():230-239. PubMed ID: 27212706 [TBL] [Abstract][Full Text] [Related]
16. [Human African trypanosomiasis]. Dumas M; Bouteille B C R Seances Soc Biol Fil; 1996; 190(4):395-408. PubMed ID: 8952890 [TBL] [Abstract][Full Text] [Related]
17. A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients. Hainard A; Tiberti N; Robin X; Lejon V; Ngoyi DM; Matovu E; Enyaru JC; Fouda C; Ndung'u JM; Lisacek F; Müller M; Turck N; Sanchez JC PLoS Negl Trop Dis; 2009 Jun; 3(6):e459. PubMed ID: 19554086 [TBL] [Abstract][Full Text] [Related]
19. Intrathecal immune response pattern for improved diagnosis of central nervous system involvement in trypanosomiasis. Lejon V; Reiber H; Legros D; Djé N; Magnus E; Wouters I; Sindic CJ; Büscher P J Infect Dis; 2003 May; 187(9):1475-83. PubMed ID: 12717630 [TBL] [Abstract][Full Text] [Related]
20. Impact of mass chemotherapy in domestic livestock for control of zoonotic T. b. rhodesiense human African trypanosomiasis in Eastern Uganda. Fyfe J; Picozzi K; Waiswa C; Bardosh KL; Welburn SC Acta Trop; 2017 Jan; 165():216-229. PubMed ID: 27570206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]